Lack of induced co-stimulation as a result of complement receptor 2 (CR2) ligation on mouse splenic B cells

被引:4
作者
Brown, SL [1 ]
Barrault, DV [1 ]
Phythian-Adams, A [1 ]
Knight, AM [1 ]
机构
[1] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland
基金
英国惠康基金;
关键词
activation; antigen processing/presentation; BCR;
D O I
10.1093/intimm/dxh350
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B cells act as efficient antigen-presenting cells if they acquire antigen via membrane-bound Ig [termed the B cell receptor (BCR)]. Ligation of the BCR leads to antigen internalization, processing and presentation to CD4(+) T cells in association with MHC class II molecules. Ligation of the BCR also leads to the generation of activation signals. One short-term consequence of this is the up-regulation of co-stimulatory molecule expression by the B cell, allowing full T cell activation. Other antigen receptors expressed by B cells can also mediate efficient antigen presentation to CD4(+) T cells. Ligating one such receptor, complement receptor 2 (CR2), has also been described to induce co-stimulatory molecule expression. If correct, this may have serious consequences for ensuring the specificity of the resultant B cell response. We have therefore investigated the effects of ligating both the BCR and CR2 independently of each other, as well as with reagents to cross-link the two receptors, in order to clarify these findings. In contrast to the effects seen upon BCR ligation, we find no evidence for co-stimulatory molecule up-regulation following CR2 ligation. As antigen presentation in the absence of co-stimulation may lead to the induction of tolerogenic or regulatory signals being delivered to T cell populations, these findings imply that the role of CR2 in B cell-mediated antigen presentation is different from that of the BCR.
引用
收藏
页码:69 / 78
页数:10
相关论文
共 57 条
[31]   ANTIGEN-SPECIFIC INTERACTION BETWEEN T-CELLS AND B-CELLS [J].
LANZAVECCHIA, A .
NATURE, 1985, 314 (6011) :537-539
[32]   A closer look at proteolysis and MHC-class-II-restricted antigen presentation [J].
Lennon-Duménil, AM ;
Bakker, AH ;
Wolf-Bryant, P ;
Ploegh, HL ;
Lagaudrière-Gesbert, C .
CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (01) :15-21
[33]  
LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990
[34]   Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling [J].
Liang, L ;
Porter, EM ;
Sha, WC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (01) :97-108
[35]   Cutting edge: Identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor [J].
Ling, V ;
Wu, PW ;
Finnerty, HF ;
Bean, KM ;
Spaulding, V ;
Fouser, LA ;
Leonard, JP ;
Hunter, SE ;
Zollner, R ;
Thomas, JL ;
Miyashiro, JS ;
Jacobs, KA ;
Collins, M .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1653-1657
[36]  
Macaulay AE, 1997, J IMMUNOL, V158, P4171
[37]   Antigen receptor triggered upregulation of CD86 and CD80 in human B cells: augmenting role of the CD21/CD19 co-stimulatory complex and IL-4 [J].
Mongini, PKA ;
Tolani, S ;
Fattah, RJ ;
Inman, JK .
CELLULAR IMMUNOLOGY, 2002, 216 (1-2) :50-64
[38]   Cytokine dependency of human B cell cycle progression elicited by ligands which coengage BCR and the CD21/CD19/CD81 costimulatory complex [J].
Mongini, PKA ;
Inman, JK .
CELLULAR IMMUNOLOGY, 2001, 207 (02) :127-140
[39]   A 13-AMINO-ACID MOTIF IN THE CYTOPLASMIC DOMAIN OF FC-GAMMA-RIIB MODULATES B-CELL RECEPTOR SIGNALING [J].
MUTA, T ;
KUROSAKI, T ;
MISULOVIN, Z ;
SANCHEZ, M ;
NUSSENZWEIG, MC ;
RAVETCH, JV .
NATURE, 1994, 368 (6466) :70-73
[40]   B7h is required for T cell activation, differentiation, and effector function [J].
Nurieva, RI ;
Mai, XM ;
Forbush, K ;
Bevan, MJ ;
Dong, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14163-14168